A detailed history of Texas Capital Bank Wealth Management Services Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Texas Capital Bank Wealth Management Services Inc holds 6,493 shares of ABBV stock, worth $1.14 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
6,493
Previous 3,102 109.32%
Holding current value
$1.14 Million
Previous $532,000 140.98%
% of portfolio
0.13%
Previous 0.06%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.84 - $199.33 $555,581 - $675,928
3,391 Added 109.32%
6,493 $1.28 Million
Q2 2024

Aug 15, 2024

SELL
$154.79 - $180.76 $134,976 - $157,622
-872 Reduced 21.94%
3,102 $532,000
Q1 2024

May 13, 2024

BUY
$159.82 - $182.1 $4,155 - $4,734
26 Added 0.66%
3,974 $723,000
Q4 2023

Feb 08, 2024

BUY
$137.6 - $154.97 $54,764 - $61,678
398 Added 11.21%
3,948 $611,000
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $4,542 - $5,258
34 Added 0.97%
3,550 $529,000
Q2 2023

Aug 09, 2023

BUY
$132.51 - $164.9 $102,562 - $127,632
774 Added 28.23%
3,516 $473,000
Q1 2023

May 11, 2023

BUY
$144.61 - $166.54 $5,929 - $6,828
41 Added 1.52%
2,742 $436,000
Q4 2022

Feb 09, 2023

BUY
$138.31 - $165.87 $11,479 - $13,767
83 Added 3.17%
2,701 $436,000
Q3 2022

Nov 03, 2022

SELL
$134.21 - $153.93 $402 - $461
-3 Reduced 0.11%
2,618 $351,000
Q2 2022

Aug 04, 2022

SELL
$137.62 - $174.96 $18,165 - $23,094
-132 Reduced 4.79%
2,621 $401,000
Q1 2022

May 02, 2022

BUY
$131.98 - $163.75 $27,319 - $33,896
207 Added 8.13%
2,753 $446,000
Q4 2021

Feb 07, 2022

BUY
$107.43 - $135.93 $4,189 - $5,301
39 Added 1.56%
2,546 $345,000
Q3 2021

Nov 05, 2021

BUY
$106.4 - $120.78 $266,744 - $302,795
2,507 New
2,507 $270,000
Q4 2020

Feb 12, 2021

SELL
$80.49 - $108.67 $511,916 - $691,141
-6,360 Closed
0 $0
Q3 2020

Nov 06, 2020

BUY
$85.91 - $100.83 $546,387 - $641,278
6,360 New
6,360 $557,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Texas Capital Bank Wealth Management Services Inc Portfolio

Follow Texas Capital Bank Wealth Management Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Texas Capital Bank Wealth Management Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Texas Capital Bank Wealth Management Services Inc with notifications on news.